Market Signal Briefing

Caroline Bishop
Dec 24, 2025 06:51

UNI price prediction shows potential 9-16% upside to $6.17-$6.53 within the next week, supported by bullish MACD momentum despite neutral RSI positioning at $5.63.

Uniswap (UNI) is currently trading at $5.63, down 6.40% in the last 24 hours, as the decentralized exchange token consolidates near critical support levels. Our comprehensive UNI price prediction analysis suggests the token is positioning for a potential breakout, with multiple analyst forecasts pointing toward upside targets in the coming days.

UNI Price Prediction Summary
• UNI short-term target (1 week): $6.17-$6.53 (+9% to +16%)
• Uniswap medium-term forecast (1 month): $5.89-$7.20 range
• Key level to break for bullish continuation: $6.21 (Upper Bollinger Band)
• Critical support if bearish: $4.85 (Strong Support/Lower Bollinger Band)

Recent Uniswap Price Predictions from Analysts
The latest UNI price prediction consensus among major analysts shows remarkable alignment, with three prominent forecasts all targeting the $5.89-$6.53 range within the next 2-3 days. Blockchain.News leads with the most optimistic UNI price target of $6.53 by December 26, citing bullish MACD momentum as a key driver. Meanwhile, CoinArbitrageBot's AI-driven analysis suggests a more conservative $5.89 target by today, while CoinCodex projects $6.17 despite noting bearish sentiment and extreme fear conditions.

This Uniswap forecast convergence around the $6.00+ level provides strong validation for our technical analysis, especially considering the current Fear & Greed Index reading of 20 (Extreme Fear) typically signals oversold conditions that precede reversals.

UNI Technical Analysis: Setting Up for Bullish Momentum
The current Uniswap technical analysis reveals a token in transition, with several indicators suggesting the recent selloff may be nearing exhaustion. The RSI at 47.95 sits in neutral territory, avoiding oversold conditions while providing room for upward movement. More importantly, the MACD histogram shows a positive reading of 0.0957, indicating bullish momentum is building despite the negative MACD line at -0.0797.

UNI's position within the Bollinger Bands at 0.5744 places it slightly above the middle band ($5.53), suggesting the token has found support above the 20-day SMA. The daily trading range of $6.08-$5.60 shows volatility compression, often a precursor to significant moves. With an Average True Range (ATR) of $0.49, we can expect moves of approximately 8-9% in either direction.

Volume analysis shows robust trading activity with $41.7 million in 24-hour volume on Binance spot, indicating continued institutional and retail interest despite the recent decline.

Uniswap Price Targets: Bull and Bear Scenarios
Bullish Case for UNI
Our primary UNI price prediction targets the $6.17-$6.53 range, representing the convergence of multiple resistance levels and analyst forecasts. The path higher begins with breaking above the immediate resistance at $6.21 (Upper Bollinger Band), which would likely trigger algorithmic buying and push UNI toward the $6.53 level identified by Blockchain.News.

A sustained move above $6.53 would target the psychological $7.00 level, where the 50-day SMA currently sits at $6.17. This Uniswap forecast assumes continued DeFi sector strength and broader cryptocurrency market stability.

Bearish Risk for Uniswap
The bearish scenario for our UNI price prediction centers around a failure to hold the $5.53 middle Bollinger Band support. A break below this level would likely test the strong support at $4.85, representing the 52-week low and Lower Bollinger Band confluence.

Key risk factors include broader market deterioration, regulatory concerns affecting DeFi protocols, or competitive pressure from emerging DEX platforms. A close below $4.85 would invalidate our bullish Uniswap forecast and target the $4.50 region.

Should You Buy UNI Now? Entry Strategy
Based on our UNI price prediction analysis, the current $5.63 level presents a reasonable entry point for traders targeting the $6.17-$6.53 range. However, we recommend a phased approach to buy or sell UNI decisions.

Primary Entry Strategy:
- Scale in between $5.55-$5.70 (current support zone)
- Set stop-loss at $5.32 (below recent swing low)
- Target 1: $6.17 (risk/reward ratio of 2.7:1)
- Target 2: $6.53 (risk/reward ratio of 4.3:1)

Conservative Approach:
Wait for a confirmed break above $6.21 with volume confirmation before establishing positions, accepting a slightly higher entry price for reduced risk.

Position Sizing:
Given the medium confidence level in our UNI price prediction, limit exposure to 2-3% of portfolio value, acknowledging the cryptocurrency market's inherent volatility.

UNI Price Prediction Conclusion
Our comprehensive Uniswap forecast points to a 9-16% upside potential over the next week, with UNI price prediction targets of $6.17-$6.53 supported by both technical indicators and analyst consensus. The bullish MACD histogram, neutral RSI positioning, and oversold market sentiment create favorable conditions for a relief rally.

Confidence Level: Medium (70%)

Key Indicators to Monitor:
- MACD line crossing above the signal line would strengthen our bullish UNI price prediction
- RSI breaking above 55 would confirm momentum shift
- Volume surge above $60 million would validate breakout moves

Timeline: Our primary Uniswap forecast timeline extends through December 26, 2025, aligning with the most optimistic analyst predictions. Failure to reach initial targets by December 27 would warrant reassessment of our UNI price prediction thesis.

The decision to buy or sell UNI ultimately depends on individual risk tolerance and market outlook, but current technical conditions favor the bullish case for patient traders willing to weather short-term volatility.

Image source: Shutterstock

uni price analysis
uni price prediction

Alvin Lang
Dec 24, 2025 06:57

BCH price prediction suggests upside to $615-630 resistance within 4-6 weeks, though bearish MACD signals caution. Critical support at $518 must hold for bullish continuation.

Bitcoin Cash is trading at a critical juncture as technical indicators present mixed signals for the weeks ahead. With BCH currently at $572.20, our comprehensive Bitcoin Cash forecast examines the path forward through early 2026.

BCH Price Prediction Summary
• BCH short-term target (1 week): $595-605 (+4% to +6%)
• Bitcoin Cash medium-term forecast (1 month): $615-630 range targeting upper Bollinger Band
• Key level to break for bullish continuation: $588 (SMA 7 resistance)
• Critical support if bearish: $518.50 (immediate support level)

Recent Bitcoin Cash Price Predictions from Analysts
The cryptocurrency analysis landscape has been notably quiet regarding specific BCH price predictions over the past three days, creating an opportunity for independent technical assessment. This absence of recent analyst coverage suggests Bitcoin Cash may be positioned for a significant move as market participants await clearer directional signals.

Without conflicting analyst opinions clouding the technical picture, the current BCH price prediction relies heavily on chart patterns and momentum indicators to guide our Bitcoin Cash forecast.

BCH Technical Analysis: Setting Up for Controlled Bullish Advance
The Bitcoin Cash technical analysis reveals a coin in consolidation mode with underlying bullish structure intact. Trading at $572.20, BCH sits comfortably above its critical 200-day moving average of $538.61, confirming the overall strong bullish trend classification.

Key technical observations supporting our BCH price prediction include the tight clustering of short-term moving averages. The SMA 7 at $587.01 and SMA 20 at $575.55 suggest recent price compression, often preceding breakout moves. The current positioning within the Bollinger Bands at 0.46 indicates BCH has room to move toward the upper band at $615.15.

However, the MACD histogram reading of -1.1313 provides a cautionary signal, suggesting bearish momentum in the short term. This creates a scenario where our Bitcoin Cash forecast must account for potential downside before the anticipated upward move materializes.

The RSI at 51.39 sits perfectly neutral, neither overbought nor oversold, providing flexibility for movement in either direction based on market catalysts.

Bitcoin Cash Price Targets: Bull and Bear Scenarios
Bullish Case for BCH
Our primary BCH price target focuses on the $615-630 zone, representing the convergence of the upper Bollinger Band ($615.15) and the 52-week high resistance area ($624.90). This represents potential upside of 7.5% to 10% from current levels.

For this Bitcoin Cash forecast to materialize, BCH must first reclaim the 7-day moving average at $587, followed by a decisive break above $588. Volume confirmation above the recent 24-hour average of $17.2 million would strengthen the bullish case significantly.

The daily ATR of $33.75 suggests that moves of $30-35 are within normal volatility parameters, making our BCH price prediction of reaching $615 technically feasible within a 4-6 week timeframe.

Bearish Risk for Bitcoin Cash
Should the current consolidation break to the downside, our Bitcoin Cash technical analysis identifies $518.50 as the immediate support level that must hold. A break below this level would target the stronger support zone around $446.90, representing potential downside of 22% from current prices.

The bearish MACD histogram serves as the primary warning signal for this scenario. If momentum continues to deteriorate while price approaches the $568.30 recent low, a more significant correction becomes probable.

Should You Buy BCH Now? Entry Strategy
Based on our BCH price prediction, the current level around $572 presents a reasonable entry point for medium-term holders, though we recommend a staged approach. Consider initial positions at current levels with additional buying planned on any dip toward $555-560.

For risk management, place stop-loss orders below $518 to protect against the bearish scenario outlined in our Bitcoin Cash forecast. Position sizing should account for the 22% downside risk to $446 in worst-case scenarios.

More aggressive traders might wait for the breakout above $588 before establishing positions, accepting slightly higher entry prices in exchange for greater trend confirmation.

BCH Price Prediction Conclusion
Our Bitcoin Cash forecast maintains a cautiously optimistic outlook with medium confidence in the $615-630 upside target over the next 4-6 weeks. The strong bullish trend structure provides foundation for upward movement, though bearish momentum indicators require careful monitoring.

Key indicators to watch for prediction confirmation include reclaiming the $587 level with volume, MACD histogram turning positive, and RSI moving above 55. Conversely, failure to hold $555 support or MACD signal line breakdown would invalidate this BCH price prediction.

The timeline for this Bitcoin Cash technical analysis to play out extends through the end of January 2026, with initial confirmation signals expected within the next 7-10 trading days. Given the mixed technical signals, maintaining appropriate risk management remains crucial regardless of market direction.

Image source: Shutterstock

bch price analysis
bch price prediction

Dogecoin may look quiet and unexciting right now, but history suggests that could be the point. Similar fractal setups in the past have shown that prolonged accumulation phases often precede explosive moves, rewarding patience rather than impulse. If the pattern holds, DOGE’s current calm could simply be the setup before the next major chase begins.

A Familiar Fractal Emerges At A Critical Inflection Point
According to a latest Dogecoin update by Cryptollica, the broader macro structure is beginning to mirror a familiar historical four-point fractal structure, with price action now sitting at Point 4. This phase closely resembles past pre-bull-run accumulation periods, where extended consolidation laid the groundwork for explosive upside moves.

The first key element of the setup is the rounded bottom formation. Zones 1 and 2 represented long stretches of low volatility and market boredom, and where accumulation took place quietly. Notably, Zone 2 acted as the launchpad for Dogecoin’s powerful 2021 rally. In the current Zone 4, price behavior is once again stabilizing into a rounded base, suggesting a similar accumulation process is underway.

Furthermore, the weekly RSI shows a recurring support zone around the 32 level, marked by a red baseline on the chart. Historically, each time RSI dropped to or hovered near the baseline of Points 1, 2, and 3, it marked a macro bottom.

Historical patterns hint at an upward move | Source: Chart from Cryptollica on X
At present, RSI has returned to this same critical support area. This reset implies that selling pressure is fading while momentum conditions are aligning for a potential shift back in favor of buyers. Taken together, this setup points to a cyclical reset rather than random market noise. 

With a bullish rounding bottom in place and RSI sitting at a historical buy zone, the structure suggests Dogecoin may be entering a prime accumulation phase. If the fractal unfolds as it did in past cycles, the current calm could precede a strong impulsive move.

$0.138: The Line That Separates Recovery From Stagnation
In a more recent update, crypto analyst Kevin explained that a successful reclaim of the $0.138 level on the 3-day to weekly timeframes would mark a major shift for Dogecoin. Such a move would place price back above the macro 0.382 Fibonacci level as well as the 200-week simple moving average.

This development would be a strong bullish signal, but it is unlikely to happen in isolation. The setup would most likely align with Bitcoin reclaiming the crucial $88,000–$91,000 zone, a range that needs to be recovered to support broader market strength and risk-on momentum. Until those conditions are met, Dogecoin continues to chop within what is considered a long-term dollar-cost-averaging zone, suggesting consolidation persists while the market waits for a decisive macro trigger.

DOGE trading at $0.13 on the 1D chart | Source: DOGEUSDT on Tradingview.com
Featured image from Getty Images, chart from Tradingview.com

Luisa Crawford
Dec 24, 2025 07:03

ATOM price prediction points to continued weakness with technical analysis suggesting $1.82 downside target. Cosmos forecast remains bearish despite minor bullish MACD signals.

Cosmos (ATOM) is trading in a precarious position at $1.93, trapped below key moving averages and showing signs of further weakness ahead. Our ATOM price prediction suggests limited upside potential in the near term, with technical indicators pointing toward a continued bearish trend through the first quarter of 2025.

ATOM Price Prediction Summary
• ATOM short-term target (1 week): $1.82 (-5.7%)
• Cosmos medium-term forecast (1 month): $1.75-$1.95 range
• Key level to break for bullish continuation: $2.08
• Critical support if bearish: $1.81

Recent Cosmos Price Predictions from Analysts
The latest analyst predictions paint a consistently bearish picture for Cosmos. CoinCodex's ATOM price target of $1.82 aligns with our technical analysis, backed by the Fear & Greed Index sitting at an extreme fear level of 20. Their medium confidence rating reflects the clarity of the bearish setup.

MEXC's more conservative $1.939 target suggests minimal movement, but their low confidence indicates uncertainty about even modest gains. The consensus among analysts shows no bullish catalysts strong enough to overcome the current downtrend, making this Cosmos forecast particularly noteworthy for its bearish alignment across multiple sources.

ATOM Technical Analysis: Setting Up for Further Decline
The Cosmos technical analysis reveals a clear bearish structure across multiple timeframes. ATOM is trading significantly below all major moving averages, with the price at $1.93 sitting 7.2% below the 20-period SMA at $2.08 and a staggering 48.4% below the 200-period SMA at $3.74.

The RSI at 34.00 suggests oversold conditions are developing, but haven't reached extreme levels that typically signal reversal bounces. More concerning is ATOM's position within the Bollinger Bands at just 0.22, indicating the price is heavily weighted toward the lower band at $1.81.

While the MACD histogram shows a slight bullish divergence at 0.0096, this minor positive momentum is insufficient to overcome the broader bearish trend. The stochastic indicators (%K at 22.50, %D at 22.74) confirm oversold conditions but lack the sharp upturn needed for reversal signals.

Cosmos Price Targets: Bull and Bear Scenarios
Bullish Case for ATOM
For any meaningful ATOM price prediction reversal, Cosmos must first reclaim the $2.08 level (20-period SMA). A break above this resistance could target the immediate resistance at $2.42, representing a 25% gain from current levels.

The bullish scenario requires:
- Volume expansion above 4 million daily average
- RSI breaking above 50 to confirm momentum shift
- MACD line crossing above the signal line with expanding histogram
- Successful retest of $2.08 as support after initial break

Bearish Risk for Cosmos
The more probable scenario sees ATOM testing the Bollinger Band lower boundary at $1.81, which coincides with strong support levels. A break below this critical level opens the door to CoinCodex's $1.82 ATOM price target, with further downside potential toward the 52-week low at $1.85.

Key bearish catalysts include:
- Failure to hold $1.91 support level
- RSI breakdown below 30 (oversold extreme)
- Volume spike on any breakdown attempts
- Broader crypto market weakness affecting altcoin sentiment

Should You Buy ATOM Now? Entry Strategy
The current technical setup suggests waiting for clearer signals before determining whether to buy or sell ATOM. For aggressive traders, a bounce play from the $1.81-$1.83 support zone offers a risk-reward opportunity with tight stop-losses.

Conservative Entry Strategy:
- Wait for break and retest of $2.08 resistance
- Set stop-loss at $1.95 (current pivot point)
- Target initial move to $2.42 resistance

Risk Management:
- Position size should not exceed 2% of portfolio given high volatility
- Daily ATR of $0.12 suggests potential for significant intraday swings
- Consider dollar-cost averaging if building long-term position

ATOM Price Prediction Conclusion
Our ATOM price prediction maintains a bearish outlook through January 2025, with high confidence in the $1.82 downside target. The Cosmos forecast suggests limited upside until technical indicators show genuine reversal signals above the $2.08 threshold.

Key indicators to monitor for this prediction include RSI breaking below 30 for oversold extremes, MACD histogram expansion in either direction, and volume confirmation on any breakout attempts. The timeline for this bearish scenario is 2-4 weeks, with the strongest probability of reaching targets before the end of January 2025.

Traders should remain cautious about timing any buy or sell ATOM decisions until clearer technical confirmation emerges from these critical support and resistance levels.

Image source: Shutterstock

atom price analysis
atom price prediction

Tony Kim
Dec 24, 2025 07:08

LTC price prediction shows potential 14-25% upside to $87-95 range if $74.66 support holds, with technical indicators suggesting cautious optimism for Litecoin's near-term forecast.

LTC Price Prediction Summary
• LTC short-term target (1 week): $78-80 (+2.6% to +5.3%)
• Litecoin medium-term forecast (1 month): $87-95 range (+14% to +25%)
• Key level to break for bullish continuation: $87.54
• Critical support if bearish: $74.66

Recent Litecoin Price Predictions from Analysts
The latest LTC price prediction analysis reveals a mixed but cautiously optimistic outlook from cryptocurrency analysts. Bitget's conservative forecast targets $77.76 in the short term, representing minimal upside based on their calculated daily growth rate of 0.014%. However, this prediction carries low confidence due to the modest projected gains.

In contrast, BitcoinEthereumNews presents a more bullish Litecoin forecast, projecting a $87-95 price range that would deliver 13-24% upside from current levels. This prediction hinges critically on LTC maintaining support above $74.66, which aligns closely with the current 52-week low of $74.29.

The consensus among analysts suggests that while bearish momentum currently dominates, LTC price prediction models indicate potential for recovery if key technical levels hold. The divergence in forecasts reflects the uncertainty surrounding Litecoin's near-term direction, with conservative analysts favoring minimal movement while others see significant upside potential.

LTC Technical Analysis: Setting Up for Potential Reversal
The current Litecoin technical analysis reveals a cryptocurrency positioned at a critical juncture. Trading at $76.00, LTC sits precariously close to its 52-week low of $74.29, representing a -41.94% decline from its yearly high of $130.91.

Key momentum indicators present a mixed picture. The RSI reading of 39.22 places Litecoin in neutral territory, avoiding oversold conditions but indicating subdued buying pressure. More encouraging is the MACD histogram at 0.1063, which suggests emerging bullish momentum despite the overall negative MACD reading of -2.7202.

The Bollinger Bands analysis shows LTC trading at the 0.2124 position within the bands, closer to the lower band at $73.35 than the upper band at $85.84. This positioning typically indicates oversold conditions and potential for mean reversion toward the middle band at $79.59.

Moving averages paint a bearish picture with LTC trading below all major timeframes: 7-day SMA ($76.64), 20-day SMA ($79.59), 50-day SMA ($86.40), and significantly below the 200-day SMA ($99.75). This alignment suggests the overall trend remains weak despite recent stabilization.

Litecoin Price Targets: Bull and Bear Scenarios
Bullish Case for LTC
The primary LTC price target for bulls centers on the $87-95 range, representing the immediate and strong resistance levels identified in the technical analysis. For this scenario to unfold, several conditions must align:

First, LTC must decisively hold above the critical $74.66 support level, which coincides with the 52-week low area. A successful defense of this level could trigger short covering and renewed buying interest. The initial target would be a move toward $80, representing the 20-day SMA and psychological resistance.

If momentum builds, the next LTC price target becomes $87.54, the immediate resistance level. Breaking this barrier would likely trigger algorithmic buying and potentially drive prices toward the $95 upper target, which aligns with the Bollinger Band upper boundary area.

Volume confirmation remains crucial for any bullish breakout. The current 24-hour volume of $19.2 million needs to expand significantly to support sustained upward movement.

Bearish Risk for Litecoin
The bearish scenario for this Litecoin forecast involves a breakdown below the critical $74.66 support level. Such a move would likely trigger stops and accelerate selling toward the next major support at $72.64, which represents both immediate and strong support levels.

A breakdown below $72.64 could see LTC testing the psychological $70 level, representing approximately 8% downside from current prices. The bearish case is supported by the weak positioning below all major moving averages and the overall cryptocurrency market uncertainty.

Risk factors include broader market weakness, Bitcoin correlation, and potential regulatory concerns that could pressure alternative cryptocurrencies like Litecoin.

Should You Buy LTC Now? Entry Strategy
The current buy or sell LTC decision requires careful consideration of risk tolerance and technical positioning. For aggressive traders, the current levels around $76 present a risk/reward opportunity with tight stop-losses.

Entry Strategy:
- Primary Entry: $75.50-76.50 range with stop-loss at $74.50
- Secondary Entry: On any dip to $74.70-75.00 with stop-loss at $73.50
- Breakout Entry: Above $80 confirmation with stop-loss at $77.50

Position sizing should remain conservative given the proximity to 52-week lows and overall market uncertainty. Risk no more than 2-3% of portfolio value on any single LTC position.

Take Profit Levels:
- First target: $80 (partial profit taking)
- Second target: $85 (additional partial profits)
- Final target: $90-95 range (remaining position)

LTC Price Prediction Conclusion
The LTC price prediction for the coming month suggests a cautiously optimistic outlook with a medium confidence level. While current technical indicators show weakness, the proximity to 52-week lows and emerging bullish divergences in momentum indicators support the $87-95 Litecoin forecast range.

The key catalyst for this prediction centers on LTC's ability to hold above $74.66 support. Success in defending this level could trigger the 14-25% recovery projected by recent analyst forecasts. However, failure to maintain support would likely result in further downside toward $70-72.

Critical indicators to monitor:
- Daily closes above $77 for bullish confirmation
- Volume expansion above 25 million for momentum validation
- RSI movement above 45 for trend shift indication
- MACD line crossing above signal line for technical confirmation

The prediction timeline suggests initial signals should emerge within 5-7 trading days, with the full $87-95 target potentially achievable within 3-4 weeks if technical conditions align favorably.

Image source: Shutterstock

ltc price analysis
ltc price prediction

Zach Anderson
Dec 24, 2025 07:15

TRX price prediction shows potential rally to $0.32 within 3-4 weeks as bullish MACD divergence emerges. TRON technical analysis reveals critical $0.29 breakout level.

TRON (TRX) is positioning for a potential breakout as technical indicators align with analyst predictions calling for upside momentum into early 2025. With the current price at $0.28, our TRX price prediction analysis suggests a measured rally could unfold if key resistance levels are conquered.

TRX Price Prediction Summary
• TRX short-term target (1 week): $0.2983 (+6.5%) - Based on technical momentum
• TRON medium-term forecast (1 month): $0.30-$0.33 range - Analyst consensus zone
• Key level to break for bullish continuation: $0.29 (immediate resistance)
• Critical support if bearish: $0.27 (Bollinger Band lower boundary)

Recent TRON Price Predictions from Analysts
The latest TRON forecast from multiple sources converges around a remarkably consistent theme. Four separate analyst predictions published on December 21st all target the $0.30-$0.33 range, suggesting strong consensus among technical analysts.

Blockchain.News leads the pack with the most aggressive TRX price prediction of $0.32, citing bullish MACD divergence as the primary catalyst. This aligns with our technical observations showing the MACD histogram turning positive at 0.0009, indicating early momentum shifts.

CoinMarketCap AI's more conservative $0.30 TRX price target incorporates fundamental catalysts, particularly TRON's integration developments and deflationary tokenomics. Meanwhile, MEXC News projects a $0.2983 target representing a 7.97% gain, while Coindataflow's $0.332791 forecast relies on the 200-day SMA trend analysis.

The consensus among these predictions creates a compelling case for upside potential, with all analysts expressing medium confidence levels - suggesting measured optimism rather than speculative euphoria.

TRX Technical Analysis: Setting Up for Controlled Breakout
Current TRON technical analysis reveals a cryptocurrency in consolidation mode, testing key inflection points. The RSI at 50.42 sits perfectly neutral, providing room for movement in either direction without overbought constraints.

The MACD configuration presents the most compelling bullish signal in our analysis. While the main MACD line remains slightly negative at -0.0002, the histogram has turned positive at 0.0009, indicating momentum is shifting from bearish to bullish. This early divergence often precedes price breakouts.

TRON's position within the Bollinger Bands at 0.5784 suggests the price is slightly above the middle band, approaching the upper resistance at $0.29. This positioning indicates controlled accumulation rather than volatile speculation.

Volume analysis from Binance shows $39.48 million in 24-hour trading, providing adequate liquidity for any potential breakout move. The relatively tight trading range between $0.28 support and $0.29 resistance creates a clear technical setup for directional movement.

TRON Price Targets: Bull and Bear Scenarios
Bullish Case for TRX
Our primary bullish TRX price prediction hinges on a decisive break above $0.29 resistance. Once cleared, the next logical target sits at $0.30 - a psychologically significant level that aligns with multiple analyst predictions.

Beyond $0.30, the TRON forecast extends to $0.32 based on measured move calculations from the current consolidation range. This represents a 14% gain from current levels and matches the most optimistic analyst target from Blockchain.News.

For the bullish scenario to materialize, TRX needs sustained volume above 50 million daily and RSI confirmation above 60. The 200-day SMA at $0.31 could provide initial resistance, but breaking through would signal longer-term trend reversal.

Bearish Risk for TRON
The primary risk to our TRX price prediction comes from a breakdown below $0.27 support. This level corresponds to both the lower Bollinger Band and a significant support zone that has held during recent consolidation.

A bearish break could target the next support at $0.26, representing a 7% decline from current levels. More concerning would be a move toward the 52-week low of $0.24, though this would require significant market-wide deterioration.

Key bearish signals to monitor include RSI falling below 45, MACD histogram returning negative, and volume spikes during downward moves exceeding 60 million daily.

Should You Buy TRX Now? Entry Strategy
Based on our TRON technical analysis, the current risk-reward profile favors a measured accumulation approach. The optimal entry strategy involves buying TRX in the $0.275-$0.28 range with a stop-loss below $0.27.

For aggressive traders, a breakout buy above $0.29 with confirmation volume offers a higher probability setup targeting the $0.32 level. This approach requires strict risk management with stops below $0.285.

Position sizing should remain conservative given the medium confidence level in current predictions. Risk no more than 2-3% of portfolio value on any single TRX trade, allowing for multiple entry opportunities if the consolidation extends.

TRX Price Prediction Conclusion
Our comprehensive analysis supports a bullish TRX price prediction with a primary target of $0.30-$0.32 over the next 3-4 weeks. The confluence of analyst consensus, bullish MACD divergence, and favorable risk-reward positioning creates a compelling setup.

Confidence level: Medium-High (70%) for reaching $0.30, Medium (60%) for achieving $0.32.

Key indicators to monitor for confirmation include a decisive break above $0.29 with volume, RSI sustained above 55, and MACD line turning positive. For invalidation, watch for breaks below $0.27 support with accompanying volume spikes.

The timeline for this TRON forecast extends through mid-January 2025, allowing sufficient time for the technical setup to mature while remaining realistic about cryptocurrency market volatility.

Image source: Shutterstock

trx price analysis
trx price prediction

Bitcoin price slipped today below $87,000, falling nearly 1%, as multiple pressures hit the market at the same time. After weeks of moving sideways between $85,000 and $90,000, Bitcoin is struggling to find strong support, leaving traders cautious.

China’s Mining Crackdown Triggers Supply PressureOne of the biggest reasons behind today’s drop is China’s renewed crackdown on Bitcoin mining. Reports show that authorities shut down large mining operations in Xinjiang earlier this month. As a result, an estimated 400,000 miners went offline in a very short period.

This sudden disruption caused Bitcoin’s network hashrate to fall by around 8%, signaling a real operational shock. When miners are forced offline, their income stops instantly. 

Many then face relocation and setup costs, which often lead them to sell Bitcoin to cover expenses. This creates real selling pressure, not speculation.

ETF Outflows Signal Institutional RotationAt the same time, institutional demand has weakened. Spot Bitcoin ETFs have now recorded three straight weeks of outflows. On December 23 alone, ETFs saw $186.6 million leave the market. BlackRock led the withdrawals with $157.3 million, followed by Fidelity and Grayscale.

This trend suggests institutions are rotating funds away from Bitcoin, at least temporarily. 

Many analysts believe that money is moving into gold, which recently hit a fresh all-time high above $4,400, strengthening the safe-haven trade.

Massive Options Expiry Adds Volatility RiskAdding more pressure is the largest Bitcoin options expiry in history. Over $23.6 billion worth of BTC options expired on Deribit, involving nearly 268,000 contracts. 

Such large expiries often cause sharp moves, especially during low-liquidity holiday weeks. Traders usually see choppy price action before expiry, followed by a clearer move afterward.

What Comes Next for Bitcoin?Despite weak sentiment, some technical signs remain hopeful. Bitcoin has printed multiple golden crosses this month, and historically, BTC rarely closes two years in a row in the red.

Still, analysts at CryptoQuant warn that if pressure continues, Bitcoin could retest the $70,000 to $56,000 range in the coming months before a stronger recovery begins.

For now, Bitcoin’s drop looks driven by policy shocks, institutional rotation, and market mechanics, not a collapse in long-term demand.

Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.

Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.

Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.

PumpFun’s PUMP token has experienced a nearly 35% decline in value over the past month, significantly underperforming the broader crypto market.

The decline comes despite the platform’s ongoing buyback program. This has raised questions on the effectiveness of revenue-backed support mechanisms in the face of sustained whale selling and a wider market downturn.

Sponsored

Sponsored

Buyback-Driven Demand Falls Short Amid Broader Sell-offPump.fun launched its buyback program for the native PUMP token in July 2025, shortly after the token’s debut. Under this mechanism, the platform allocates 100% of its revenue to purchasing PUMP. This creates consistent and substantial daily buy pressure.

Since inception, these buybacks have amounted to approximately $218.1 million in total purchases. The network has deployed $32.7 million in buybacks over the past 30 days alone.

In theory, token buybacks are typically considered bullish, as they reduce circulating supply and provide sustained demand support.

However, this aggressive, revenue-backed strategy has not been sufficient to offset the broader market downturn’s impact. Since early October, the crypto market has faced mounting headwinds.

The total cryptocurrency market capitalization has declined by nearly 30%, with major assets such as Bitcoin (BTC) and Ethereum (ETH) experiencing substantial losses.

PUMP has not been immune to this trend. The token has dipped by approximately 35% over the past 30 days.

Sponsored

Sponsored

“PumpFun is allocating 100% of its revenue to PUMP buybacks, amounting to nearly $1 million in daily buy pressure. Despite this, the token is down over 80% from its ATH and about 30% below its previous all time low (pre-buybacks). This clearly shows that buybacks, no matter how aggressive, have limited impact in a market downturn especially when the token’s utility is weak or constrained,” an analyst wrote.

The downtrend extended further today, with the altcoin falling an additional 6.9%. At press time, it was trading around $0.0017, a price last seen during the October market-wide sell-off.

Pump.fun (PUMP) Price Performance. Source: BeInCrypto MarketsPUMP’s challenges have been further exacerbated by recent whale activity. One notable whale recently deposited 3.8 billion PUMP, valued at approximately $7.57 million, into FalconX after holding the position for three months. This whale withdrew the tokens from Binance at $19.53 million, leading to an unrealized loss of $12.22 million.

Data from Nansen indicates that, over the past 30 days, balances of large investors, defined as wallets holding more than 1 million PUMP tokens, have declined by 13.07%. When large holders exit positions at substantial losses, it often reflects waning confidence in the token.

Overall, PUMP’s performance highlights the limits of even aggressive, revenue-backed buybacks during broader market downturns. As long as selling pressure from large holders persists and investor risk appetite continues to weaken, buybacks alone are unlikely to provide sustained price support.

Ripple executive Reece Merrick has predicted that institutional adoption is going to accelerate at a rapid pace in 2026.

Bitcoin continues to slip against gold, testing the 'safe haven' tradeGold is rallying on rate cut expectations and geopolitical risk, while bitcoin has struggled to hold key psychological levels and remains sensitive to the same forces that tend to hit equities and other risk assets.Updated Dec 24, 2025, 6:55 a.m. Published Dec 24, 2025, 6:55 a.m.

Gold is making fresh highs while bitcoin is struggling to hold key levels, reopening a debate crypto investors never fully settled. If bitcoin is supposed to be digital gold, this is the kind of tape it is meant to win. Right now, it is not.

The question is getting louder because gold is rallying on rate cut expectations and geopolitical risk, while bitcoin has struggled to hold key psychological levels and remains sensitive to the same forces that tend to hit equities and other risk assets.

STORY CONTINUES BELOW

Gold is up more than 70% this year, with others precious metal silver has rallied about 150%, putting both on track for their strongest annual gains since 1979.

Platinum also pushed to record levels, extending a broader surge across precious metals as investors return to the category as a hedge against geopolitical volatility and long-run currency risk.

Part of what is holding bitcoin back is positioning. The market is still digesting a long stretch of leverage-led trading, and each rebound has been met by quick profit-taking over the past week.

Macro is another drag. Even when traders expect rate cuts, bitcoin tends to need clear conditions for risk-taking, not just a softer path for policy. Bond yields have been volatile, the dollar has whipsawed, and markets have repeatedly shifted into a “preserve capital” mood. That usually helps gold first.

David Miller, chief investment officer at Catalyst Funds and portfolio manager of the Strategy Shares Gold Enhanced Yield ETF, said the divergence is hard to ignore.

“Gold has had a record year, up over 60%. But bitcoin too. You still have this situation where it’s clearly not digital gold,” Miller said, adding that “gold can have a record year while bitcoin is down in the same year.”

Miller said bitcoin can still make sense in portfolios over the long run, especially as a hedge against fiscal expansion and currency debasement. But he argued gold still plays a different role because it is already treated as a reserve asset by central banks.

“What gold does that bitcoin definitely can’t is serve as an actual alternative reserve asset to a currency,” Miller said. “Bitcoin is really a retail play, whereas gold is very much institutional.”

World Gold Council data shows holdings in gold-backed ETFs rose in every month this year except May, pointing to consistent accumulation rather than a short-lived trading burst. Holdings in State Street’s SPDR Gold Trust, the largest gold ETF, have increased by more than 20% in 2025.

Several Wall Street banks have also carried bullish views into next year. Goldman Sachs has forecast prices could rise toward $4,900 an ounce in 2026 under its base case, with risks skewed higher.

More For You

State of the Blockchain 2025

Dec 19, 2025

L1 tokens broadly underperformed in 2025 despite a backdrop of regulatory and institutional wins. Explore the key trends defining ten major blockchains below.

What to know:

2025 was defined by a stark divergence: structural progress collided with stagnant price action. Institutional milestones were reached and TVL increased across most major ecosystems, yet the majority of large-cap Layer-1 tokens finished the year with negative or flat returns.

This report analyzes the structural decoupling between network usage and token performance. We examine 10 major blockchain ecosystems, exploring protocol versus application revenues, key ecosystem narratives, mechanics driving institutional adoption, and the trends to watch as we head into 2026.

View Full Report

More For You

ETH, SOL, ADA slump as bitcoin weakness lingers despite record stocks jump

1 hour ago

Investors are showing increased risk aversion, with significant outflows from crypto investment products last week.

What to know:

Bitcoin and major cryptocurrencies declined as the total crypto market value fell 1.4% to $2.97 trillion.Global stocks reached new highs, with MSCI’s All Country World Index rising for a fifth consecutive session.Investors are showing increased risk aversion, with significant outflows from crypto investment products last week.Read full story

Bitcoin is shaping up to end the year in the red, which will be just the fourth year in history it has done so.

Bitcoin is currently down 7% so far YTD, and it has only ended the year in the red in 2014, 2018, and 2022. All three were bear market years, and 2025 isn’t, leading analysts and experts to ask: Is something broken?

Many are specifically pointing at October 10, which saw BTC prices crash 10%, losing over $12,000 in a day or so in the industry’s largest leverage flush.

“WTF happened on October 10th? Exchanges are saying they are fine. Market Makers are saying they are fine,” asked analyst ‘Max Crypto’ who added that crypto prices feel like a few big entities are selling non-stop.

“This has really started to feel like a Luna event, when everyone said that we are fine, and it ended horribly.”

WTF happened on October 10th?

Exchanges are saying they are fine.

MMs are saying they are fine.

And the crypto prices feel like a few big entities are selling non-stop.

This has really started to feel like Luna event, when everyone said that we are fine and it ended horribly. pic.twitter.com/D9RNefKgT7

— Max Crypto (@MaxCrypto) December 23, 2025

Did October 10 Break Crypto?
“Oct. 10 was the pivotal moment to where we sit today, and the overhang of ‘Crashtober’ still haunts us,” said investor George Bodine.

The October 10 calamity occurred coincident with record runs in gold and silver, both of which did have momentum, he said before adding, “I have never seen the fundamentals behind Bitcoin as strong as this year.”

“October 10 wasn’t just ugly – it exposed problems that still haven’t been fixed, which is why the market feels so bad even now,” said crypto analyst Scott Melker.

Liquidity remains severely compromised, and market makers have become more cautious, not less, making this worse than before, he said.

Additionally, altcoins show no genuine recovery, bleeding whenever Bitcoin weakens without attracting new capital. This indicates money is exiting the market entirely rather than rotating between assets, contrary to what healthy market behavior would show.

You may also like:

Bitcoin Transactions Are Cheap Again, But Miners Are Paying the Price

VanEck Says Bitcoin Hashrate Dip Could Set Up 2026 Rally

The Real Reason Bitcoin Is Lagging Behind Gold Right Now

“October 10 broke something psychologically. It reminded everyone that this market can still just… fall apart. And once that realization sets in, behavior changes for a long time.”

Until liquidity, participation, and conviction come back together, rallies will feel fragile, and selloffs will feel fast, he said.

Is It All That Bad?
Analyst ‘CrediBULL Crypto’ opined that the event didn’t break anything.

“It was a massive deleveraging event, however, and we can see aggregate OI [open interest] has been bleeding ever since – which means confidence in positioning via perps has definitely taken a hit.”

They said that if the price bottoms in this region and continues to rise, “we will see traders come back to the market like they always do, and OI will begin to rise once more.”

Less leverage in the system is not a bad thing, “as it simply means this next rally is even more sustainable than the prior one.”

Bitcoin was trading down on the day, struggling to maintain momentum above $87,000 at the time of writing.

Tags:

According to Grayscale Investments, the global push to tokenize real-world assets is only beginning, and Chainlink could become one of the key technologies driving that expansion. 

In an interview on the Thinking Crypto podcast, Grayscale Head of Research Zach Pandl said that just a small portion of global assets are currently on blockchain networks, but adoption could accelerate significantly over the next five to ten years as traditional finance moves on-chain.

Chainlink’s Role in Bridging Crypto and Traditional FinanceGrayscale recently launched a Chainlink ETF, converting its existing Chainlink investment vehicle into an exchange-traded fund. Pandl said the ETF structure makes it easier for investors to gain exposure to what he described as one of the most important projects in the crypto ecosystem.

According to Pandl, Chainlink acts as a bridge between blockchains and traditional finance by providing reliable data, compliance tools, and integrations needed for tokenized assets, stablecoins, and decentralized finance to function at scale.

“Chainlink is really the connective tissue between the crypto ecosystem and traditional finance,” he said. “It’s not a bet on one blockchain, but exposure to where the entire industry is going

ETFs Expand Beyond Bitcoin and EthereumPandl also highlighted Grayscale’s expanding lineup of crypto ETFs, including products tied to XRP, Solana, Dogecoin, and Chainlink. He said regulatory clarity has accelerated the pace at which new crypto ETFs are coming to market, following the long approval process for Bitcoin and Ethereum ETFs.

XRP, originally built for payments, is now expanding into broader use cases, while Solana continues to attract activity due to its speed and low costs. Dogecoin, Pandl noted, represents a different segment of the market but reflects the growing diversity of investor interest.

Grayscale has also shown interest in privacy-focused assets such as Zcash, which Pandl said addresses a major gap in public blockchain systems.

“If public blockchains are going to transform finance, they must support privacy,” Pandl said. “Institutions will not operate on systems where payrolls, balances, and transactions are fully visible.”

Market Pullback Seen as Typical, Not a Cycle TopAddressing recent market weakness, Pandl said Bitcoin’s roughly 30% decline from its recent highs may feel severe but is consistent with past bull markets.

He emphasized that Bitcoin frequently experiences multiple pullbacks of 10% to 30% during strong cycles and that Grayscale does not see signs of a major, long-term downturn.

“A 30% pullback is actually about an average drawdown for Bitcoin,” Pandl said. “We do not believe we are on the cusp of a larger multi-year decline.”

Pandl said two forces continue to support crypto markets: rising demand for alternative stores of value amid growing debt and inflation risks, and increased institutional access driven by clearer regulations.

He added that capital continues to flow into crypto through ETFs, platforms, and institutional products as regulatory barriers ease.

Tokenization Could Grow 1,000xPandl said tokenized assets currently total around $30–35 billion, which represents just a tiny fraction of global equity and bond markets worth roughly $300 trillion.

He believes tokenized assets could grow by as much as 1,000 times over the next five years as traditional financial instruments move on-chain.

Tokenization, he said, could allow markets to operate around the clock, speed up settlement times, and unlock new financial services such as on-chain lending and collateralization.

Grayscale sees platforms like Ethereum as likely hosts for tokenized assets, while infrastructure providers like Chainlink enable the data and connectivity required for adoption.

Volatility Likely to Remain, But Diversification Value StaysPandl said crypto’s correlation with equities has increased as the market has grown, but it still behaves more like a commodity than a stock index.

Bitcoin and other large digital assets may move with equities at times, he said, but often follow their own fundamentals, making them useful portfolio diversifiers.

While acknowledging the risks and volatility involved in crypto investing, Pandl said current prices may offer long-term investors a chance to build positions.

“If you’re optimistic about the long-term vision, a lower price is an opportunity,” he said. “From our perspective, this is a good time to begin accumulating the asset class.”

Grayscale remains optimistic about crypto’s long-term outlook, citing continued innovation, growing institutional interest, and steady progress toward regulatory clarity in the United States.

Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.

Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.

Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.

8h15 ▪
4
min read ▪ by
Luc Jose A.

Summarize this article with:

The crypto market, still as unpredictable as ever, enters a decisive phase at the end of the year. The open interest of Bitcoin perpetual contracts reaches new heights, fueling speculation about a possible year-end rally. According to Glassnode, this increase is accompanied by a doubling of funding rates, demonstrating growing trader confidence. However, this dynamic raises concerns. Special attention is needed in light of these speculative movements that could disrupt prices in the short term.

In Brief

The significant increase in the open interest of Bitcoin perpetual contracts reveals growing enthusiasm among traders for this crypto.
A comprehensive analysis of the doubling of funding rates is a major indicator of strengthened optimism among investors.
The risks associated with an increasingly speculative market underscore the possibility of a quick correction if the situation deteriorates.
The potential consequences on Bitcoin’s price and trader behavior in the coming months are multiple.

An Increase in Open Interest
In the latest Glassnode report, it is noted that the open interest on Bitcoin perpetual contracts has surpassed 310,000 BTC, while the crypto price briefly touched $90,000 last Monday.

This leap, although influential, is only the latest in a series of indicators suggesting that the market is preparing for a potential surge at the end of the year.

Here are the key points to take away from this situation :

The increase in open interest (OI) : open interest has surpassed 310,000 BTC, a notable rise reflecting growth in open positions on Bitcoin perpetual contracts ;

An increase in funding rates : funding rates have doubled, rising from 0.04 % to 0.09 %, reflecting bullish anticipation among traders ;

Growing trader confidence : this rise in OI and funding rates indicates strong confidence in the possibility of a bullish Bitcoin move by year-end ;

Majority long positions : the Glassnode report signals a strong return of long positions, suggesting investors are betting on a short-term Bitcoin increase.

This phenomenon of increasing open interest fits into a logic of increasingly complex derivatives markets, where long positions are taken on credit. While this may signal growing market confidence, some experts warn about the risk it represents.

The rise in funding rates and the intensification of long positions could indicate overexposure, fueling concerns about a possible sharp correction if prices do not follow this anticipated bullish trajectory.

Increased Volatility on the Horizon
While the increase in open interest and long positions seems to reflect traders’ bullish conviction, the situation could also turn against them.

The Glassnode report highlighted that rising funding rates can also signal a potentially overheated market. Indeed, when funding becomes too high, it can suggest the market is beginning to detach from its fundamentals, with increasingly risky long positions.

In this situation, a simple correction could trigger a domino effect, forcing traders to liquidate their short positions. The magnitude of the correction could be even greater given that leverage exposure has significantly increased in recent days.

Another factor adding uncertainty to the situation is the massive expiration of Bitcoin options, with over $23 billion in contracts maturing on December 26. The concentration of these contracts around the $85,000 and $100,000 price levels could lead to particularly volatile market movements.

Moreover, Deribit data specify that “long contracts at $100,000 and $120,000 are particularly exposed to loss if targets are not met”. Open positions above the $96,000 price, considered the “max pain”, could lead to massive price adjustments as expiration approaches.

While optimism around long positions on Bitcoin strengthens, the risks of increased volatility remain. With the imminent expiration of options and intense speculation, the Bitcoin price could undergo major fluctuations as current dynamics could precipitate sharp market moves.

Maximize your Cointribune experience with our "Read to Earn" program! For every article you read, earn points and access exclusive rewards. Sign up now and start earning benefits.

Join the program

A

A

Lien copié

Luc Jose A.

Diplômé de Sciences Po Toulouse et titulaire d'une certification consultant blockchain délivrée par Alyra, j'ai rejoint l'aventure Cointribune en 2019.
Convaincu du potentiel de la blockchain pour transformer de nombreux secteurs de l'économie, j'ai pris l'engagement de sensibiliser et d'informer le grand public sur cet écosystème en constante évolution. Mon objectif est de permettre à chacun de mieux comprendre la blockchain et de saisir les opportunités qu'elle offre. Je m'efforce chaque jour de fournir une analyse objective de l'actualité, de décrypter les tendances du marché, de relayer les dernières innovations technologiques et de mettre en perspective les enjeux économiques et sociétaux de cette révolution en marche.

DISCLAIMER

The views, thoughts, and opinions expressed in this article belong solely to the author, and should not be taken as investment advice. Do your own research before taking any investment decisions.

Japan's top oil refiner Eneos is leading rival bidders for Chevron's stake in a Singapore refinery, with a deal nearing completion, though potential delays remain, Bloomberg News reported on Wednesday, citing people familiar with the matter.

Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis Paris, December 24, 2025. The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) for the new drug application of tolebrutinib to treat non-relapsing secondary progressive multiple sclerosis (nrSPMS) in adult patients.

Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline

Paris, December 24, 2025. Sanofi announced today that it has entered into an agreement to acquire Dynavax Technologies Corporation (Dynavax), a publicly traded vaccines company with a marketed adult hepatitis B vaccine (HEPLISAV-B®) and differentiated shingles vaccine candidate. The acquisition augments Sanofi’s presence in adult immunization by bringing together Dynavax’s vaccines with Sanofi’s global scale, development capabilities and commercial reach.

Dynavax’s adult hepatitis B vaccine HEPLISAV-B is currently marketed in the US and is differentiated by its two-dose regimen over one month, which enables high levels of seroprotection faster than other hepatitis B vaccines, which are given in three doses over six months.

The acquisition also includes Dynavax’s shingles vaccine candidate (Z-1018), which is currently in phase 1/2 clinical development and additional vaccine pipeline projects.

“Dynavax enhances Sanofi’s adult immunization presence by adding differentiated vaccines that complement Sanofi’s expertise,” said Thomas Triomphe, Executive Vice President, Vaccines, Sanofi. “Its marketed adult hepatitis B vaccine and shingles candidate bring new options to our portfolio and underscore our commitment to providing vaccine protection across the lifespan.”

“Joining Sanofi will provide the global scale and expertise needed to maximize the impact of our vaccine portfolio,” said Ryan Spencer, Chief Executive Officer, Dynavax. “We believe Sanofi’s commercial reach, development capabilities, and commitment to evidence-based immunization will amplify the opportunity for HEPLISAV-B and our innovative pipeline to address important public health needs, further advancing our mission to help protect the world against infectious disease. We are confident that this transaction – and the compelling value it provides – is in the best interests of the Company and its stockholders.”

Hepatitis B and shingles represent a significant public unmet health need and adult vaccination opportunities. In the US alone, nearly 100 million adults born before 1991 remain unvaccinated, with many potentially at risk for infection. Chronic infection with the hepatitis B virus can cause liver damage and lead to cirrhosis and liver cancer. Shingles, which is caused by the varicella zoster virus, affects one in three adults over their lifetime, according to the World Health Organization. In most people, shingles causes a painful, itchy rash but, in some cases it can lead to long-term nerve pain, serious eye infections that can damage the vision, and, rarely, to dangerous inflammation of the brain.

Financial considerations
Under the terms of the merger agreement, Sanofi will commence a cash tender offer to acquire all outstanding shares of Dynavax for $15.50 per share in cash, reflecting a total equity value of approximately $2.2 billion.

The transaction has been unanimously approved by the Dynavax board of directors. The consummation of the tender offer is subject to customary closing conditions, including the tender of a number of shares of Dynavax common stock that represent at least a majority of the outstanding shares of Dynavax common stock, the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, certain foreign regulatory filings and clearances, and other customary conditions.

If the tender offer is successfully completed, then following the successful completion of the tender offer, a wholly owned subsidiary of Sanofi will merge with and into Dynavax, and all of the outstanding Dynavax common stock that are not tendered in the tender offer will be converted into the right to receive the same $15.50 per share in cash offered to Dynavax shareholders in the tender offer.

Sanofi plans to fund the acquisition with available cash resources.

The agreement to acquire Dynavax is not expected to have any impact on Sanofi’s financial guidance for 2025. Subject to the satisfaction or waiver of customary closing conditions, the acquisition is expected to close in the first quarter of 2026.

About HEPLISAV-B
HEPLISAV-B is an adult hepatitis B vaccine that combines hepatitis B surface antigen with Dynavax's vaccine adjuvant, a toll-like receptor (TLR) 9 agonist, to enhance the immune response. 

HEPLISAV‑B is an injection given to adults 18 years of age and older to help prevent infection caused by the hepatitis B virus. HEPLISAV‑B is usually given in the arm muscle. HEPLISAV‑B is given in two doses, one month apart, by a healthcare provider.

Important safety information
Do not take HEPLISAV-B if you have a history of severe allergic reaction after a previous dose of any hepatitis B vaccine, or to any ingredient of HEPLISAV‑B, including yeast. HEPLISAV‑B must be given by a medical professional, who will monitor you afterwards, to check for allergic reaction. If you are immunocompromised, or receiving immunosuppressant therapy, you may have less of an immune response to HEPLISAV‑B.

Some people have hepatitis B infection without being aware of it or showing any symptoms. If you already have hepatitis B present in your body, HEPLISAV‑B may not prevent hepatitis B infection.
The most common side effects include pain at the injection site, tiredness, and headache.
Tell your provider if you are pregnant or plan to become pregnant or are breast feeding.
Vaccination with HEPLISAV‑B may not protect all individuals.

About Sanofi
Sanofi is an R&D driven, AI-powered biopharma company committed to improving people's lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people's lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time.
Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY

About Dynavax
Dynavax is a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines to help protect the world against infectious diseases. The Company has two commercial products, HEPLISAV-B® vaccine [Hepatitis B Vaccine (Recombinant), Adjuvanted], which is approved in the US, the European Union and the United Kingdom for the prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. For more information about our marketed products and development pipeline, visit Dynavax.com.

Sanofi Media Relations
Sandrine Guendoul | +33 6 25 09 14 25 | [email protected]
Evan Berland | +1 215 432 0234 | [email protected]  
Léo Le Bourhis | +33 6 75 06 43 81 | [email protected]  
Victor Rouault | +33 6 70 93 71 40 | [email protected]
Timothy Gilbert | +1 516 521 2929 | [email protected]
Léa Ubaldi | +33 6 30 19 66 46 | [email protected]
Ekaterina Pesheva | +1 410 926 6780 | [email protected]

Sanofi Investor Relations
Thomas Kudsk Larsen | +44 7545 513 693 | [email protected]  
Alizé Kaisserian | +33 6 47 04 12 11 | [email protected]
Keita Browne | +1 781 249 1766 | [email protected]
Nathalie Pham | +33 7 85 93 30 17 | [email protected]
Thibaud Châtelet | +33 6 80 80 89 90 | [email protected]
Yun Li | +33 6 84 00 90 72 | [email protected]

Additional Information for US Shareholders and Where to Find It
The tender offer for the outstanding shares of Dynavax Technologies Corporation common stock (“Dynavax”) referenced in this communication has not yet commenced. This communication is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell shares of Dynavax, nor is it a substitute for the tender offer materials that Sanofi and its acquisition subsidiary will file with the US Securities and Exchange Commission (the “SEC”) upon commencement of the tender offer. At the time the tender offer is commenced, Sanofi and its acquisition subsidiary will file tender offer materials on Schedule TO, and Dynavax will file a Solicitation/Recommendation Statement on Schedule 14D-9 with the SEC with respect to the tender offer. The tender offer materials (including an Offer to Purchase, a related Letter of Transmittal and certain other tender offer documents) and the Solicitation/Recommendation Statement will contain important information. HOLDERS OF SHARES OF DYNAVAX ARE URGED TO READ THESE DOCUMENTS WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION THAT DYNAVAX STOCKHOLDERS SHOULD CONSIDER BEFORE MAKING ANY DECISION REGARDING TENDERING THEIR SHARES. The Offer to Purchase, the related Letter of Transmittal and certain other tender offer documents, as well as the Solicitation/Recommendation Statement, will be made available to all holders of shares of Dynavax at no expense to them. The tender offer materials and the Solicitation/Recommendation Statement will be made available for free at the SEC’s web site at www.sec.gov. Additional copies may be obtained for free by contacting Sanofi’s Investor Relations Team at [email protected] or on Sanofi’s website at https://www.sanofi.com/en/investors.

In addition to the Offer to Purchase, the related Letter of Transmittal and certain other tender offer documents, as well as the Solicitation/Recommendation Statement, Sanofi files annual and special reports and other information with the SEC and Dynavax files annual, quarterly and special reports and other information with the SEC. You may read and copy any reports or other information filed by Sanofi and Dynavax at the SEC public reference room at 100 F. Street, N.E., Washington D.C. 20549. Please call the Commission at 1-800-SEC-0330 for further information on the public reference room. Sanofi’s and Dynavax’s filings with the SEC are also available to the public from commercial document-retrieval services and at the website maintained by the SEC at www.sec.gov.

Sanofi forward looking statement
This press release contains forward-looking statements that are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those implied by the forward-looking statements. Forward-looking statements are statements that are not historical facts and may include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified by the words “expects”, “anticipates”, “believes”, “intends”, “estimates”, “plans”, “will be” and similar expressions. Although Sanofi’s management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Sanofi, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, unexpected regulatory actions or delays, or government regulation generally, that could affect the availability or commercial potential of the product, or the fact that the product may not be commercially successful, and risks related to Sanofi’s and Dynavax’s ability to complete the acquisition on the proposed terms or on the proposed timeline or at all, including the receipt of required regulatory approvals, the risk that the conditions to the closing of the transaction may not be satisfied, the possibility that competing offers will be made, the risk of securityholder litigation relating to the proposed acquisition, including resulting expense or delays, other risks associated with executing business combination transactions, such as the risk that the businesses will not be integrated successfully, that such integration may be more difficult, time-consuming or costly than expected or that the expected benefits of the acquisition will not be realized, risks related to future opportunities and plans for the combined company, including uncertainty of the expected financial performance and results of the combined company following completion of the proposed acquisition, disruption from the proposed acquisition making it more difficult to conduct business as usual or to maintain relationships with customers, employees, manufacturers, suppliers or patient groups, and the possibility that, if the combined company does not achieve the perceived benefits of the proposed acquisition as rapidly or to the extent anticipated by financial analysts or investors, the market price of Sanofi’s shares could decline, as well as other risks related to Sanofi’s and Dynavax’s respective businesses, including the ability to grow sales and revenues from existing products and to develop, commercialize or market new products, competition, including potential generic competition, the uncertainties inherent in research and development, including future clinical data and analysis, regulatory obligations and oversight by regulatory authorities, such as the FDA or the EMA, including decisions of such authorities regarding whether and when to approve any drug, device or biological application that may be filed for any product candidates as well as decisions regarding labelling and other matters that could affect the availability or commercial potential of any product candidates, the absence of a guarantee that any product candidates, if approved, will be commercially successful, the future approval and commercial success of therapeutic alternatives, Sanofi’s ability to benefit from external growth opportunities, to complete related transactions and/or obtain regulatory clearances, risks associated with intellectual property and any related pending or future litigation and the ultimate outcome of such litigation, trends in exchange rates and prevailing interest rates, volatile economic and market conditions, cost containment initiatives and subsequent changes thereto, and the impact that global crises may have on us, our customers, suppliers, vendors, and other business partners, and the financial condition of any one of them, as well as on our employees and on the global economy as a whole. While the list of factors presented here is representative, no list should be considered a statement of all potential risks, uncertainties or assumptions that could have a material adverse effect on companies’ consolidated financial condition or results of operations. The foregoing factors should be read in conjunction with the risks and cautionary statements discussed or identified in the public filings with the US Securities and Exchange Commission (the “SEC”) and the Autorité des marchés financiers made by Sanofi, including those listed under “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Statements” in Sanofi’s annual report on Form 20-F for the year ended December 31, 2024 and its other filings with the SEC and the current reports on Form 8-K, quarterly reports on Form 10-Q and annual reports on Form 10-K and other filings with the SEC filed by Dynavax. The forward-looking statements speak only as of the date hereof and, other than as required by applicable law, Sanofi and Dynavax do not undertake any obligation to update or revise any forward-looking information or statements. 

Press Release

Costco stock has been a surprising loser this year. Can it get back on track?

Costco Wholesale (COST +0.56%) has been one of the most reliable stocks to own in the retail sector and beyond over its history.

The membership-based warehouse retailer has developed a winning business model based on selling high-quality bulk goods at bargain prices, and has established a reputation as a top retailer based on high customer satisfaction scores and strong renewal rates.

Over the last ten years, Costco stock has jumped 430%, easily outperforming the S&P 500, but over the last year, the stock has struggled as its lofty valuation seemed to drive a sell-off, despite solid results. Year-to-date through Dec. 23, the stock is down 7%, and it's fallen more than 20% since its peak early in the year.

That pullback could set up a buying opportunity for the stock. To determine whether that's true, let's take a look at where the stock might be in 3 years.

Image source: Getty Images.

Costco's current growth trajectory
While most brick-and-mortar retailers of Costco's size are pumping the brakes on new stores, Costco is expanding across the board. It's adding new stores domestically and abroad, and it's growing through same-store sales and e-commerce sales.

In the fiscal year ended in August 2025, Costco reported 7.6% comparable sales growth adjusted for foreign currency exchange and gasoline prices, and e-commerce sales jumped 16.1%. That performance drove net sales up 8.1% to $269.9 billion.

Total paid members, which make up another key revenue stream for Costco, rose 6.3% to 81 million in 2025, pushing membership fee income up 10.3% to $5.3 billion. That's important because Costco's membership fees essentially flow straight to the bottom line, and it runs its retail business nearly at cost. Costco opened 24 net new warehouses in fiscal 2025, bringing its total to 914, and plans to open another 30 net new stores in 2026.

What Costco could look like in 2028
Based on Costco's current trajectory, it's not too hard to extrapolate the figures to determine what the business might look like in three years.

If net sales grow by 8% over the next three years, they will reach $340 billion. If membership income grows at a similar 10% pace to what we saw last year, it would reach $7.1 billion, which is essentially profit, giving it $347.1 billion in revenue. Costco should have around 1,000 stores worldwide by then, and around 107.8 million members.

Estimating Costco's bottom-line profit is a little trickier, as there are more variables that come into play, but Costco's business is built on low margins since it attracts customers by keeping prices low. Over most of its history, its gross margin has tracked between 12% and 13%, and its operating margin has been between 3% and 4% for most of the last decade.

If Costco's 3.8% operating margin from last year holds steady and it has $347 billion in revenue, it would have $13.1 billion in operating income in fiscal 2028. Costco's interest income and expense could change significantly between now and then, depending on interest rates so we'll assume they will be flat at a net interest income of $435 million. If its tax rate holds steady at around 25%, the company would have $22.82 in earnings per share, assuming flat growth in shares outstanding, up 25% from where it is today.

That may be a conservative estimate as it doesn't assume any margin expansion, but it also seems fair based on the numbers we have. Costco could also pay another special dividend before then, as its last one came at the end of 2023.

Today's Change

(

0.56

%) $

4.76

Current Price

$

854.76

Is Costco a buy?
Based on the $22.82 EPS forecast in 2028, Costco trades at a price-to-earnings ratio of 37.5. Despite falling 20% from its peak this year, Costco still looks expensive, trading at a P/E of 46 based on trailing earnings.

I think being patient with the stock makes sense here, especially with some of the pressure on consumer discretionary spending. If the stock pulls back another 10%, that would be a more attractive price, considering its forecast over the next three years.

, /PRNewswire/ -- WuXi Biologics (2269.HK) has once again raised the bar for sustainability commitment and transparency. The company has been honored by the Hong Kong ESG Reporting Awards (HERA) 2025 for Outstanding ESG Disclosure, marking a new milestone in its dedication to openness and accountability.

This recognition follows last year's ESG Report Benchmark Award from HERA, verifying the consistency of WuXi Biologics' progressive ESG journey. Beyond assuring compliance, ESG reporting is a strategic lever that helps gain trust and strengthen confidence among global clients, investors, regulators, and other stakeholders.

Why does this matter? In today's business landscape, transparent ESG disclosure is a competitive advantage. WuXi Biologics' detailed reporting on its sustainability targets and progress – such as corporate governance, talent development and GHG emission reduction – reassures stakeholders that the company is driving meaningful change and shaping the future of Green CRDMO.

Dr. Chris Chen, WuXi Biologics CEO and Chairman of the ESG Committee, commented, "Transparency is the cornerstone of trust. We firmly believe that openly sharing our ESG journey is essential, because only through collaboration can we help to create lasting value that contributes positively to society and the environment. Receiving the ESG Disclosure Award not only validates our efforts, but also inspires us to continue raising the bar as we lead the industry toward a more responsible and sustainable future."

As a participant of the United Nations Global Compact (UNGC) and the Pharmaceutical Supply Chain Initiative (PSCI), WuXi Biologics proactively advocates sustainability and has earned widespread recognitions for its efforts. The company was granted an MSCI AAA Rating; awarded an EcoVadis Platinum Medal; listed in the Dow Jones Sustainability Indices (DJSI); named to the CDP "A List" for Climate Change, Water Security, Supplier Engagement Assessment; given the highest negligible-risk rating by Sustainalytics, and recognized as a Sustainalytics industry and regional ESG top-rated company for five consecutive years; selected as a Constituent of the FTSE4Good Index Series; listed in the Hang Seng ESG 50 Index; and rated as Prime by ISS ESG Corporate Rating.

About WuXi Biologics

WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and manufacture biologics – from concept to commercialization – for the benefit of patients worldwide.

With over 12,000 skilled employees in China, the United States, Ireland, Germany and Singapore, WuXi Biologics leverages its technologies and expertise to provide customers with efficient and cost-effective biologics discovery, development and manufacturing solutions. As of June 30, 2025, WuXi Biologics is supporting 864 integrated client projects, including 24 in commercial manufacturing.

WuXi Biologics regards sustainability as the cornerstone of long-term business growth. The company continuously drives green technology innovations to offer advanced end-to-end Green CRDMO solutions for its global partners while consistently achieving excellence in Environment, Social and Governance (ESG). Committed to creating shared value, it collaborates with all stakeholders to foster positive social and environmental impacts and promote responsible practices that empower the entire value chain.

For more information about WuXi Biologics, please visit: www.wuxibiologics.com.

Contacts

ESG
[email protected]

Media
[email protected]

SOURCE WuXi Biologics

Japan's Sapporo Holdings is planning to sell its real estate business to a consortium led by private equity firm KKR for 400 billion yen ($2.6 billion), public broadcaster NHK reported Wednesday.

Sapporo, known for its beer brewing business, is looking to concentrate management resources on its core operations, and has been "negotiating the price and terms with several investment funds and others," NHK said, according to a Google translation of the article in Japanese.

Sapporo's real estate holdings include the Yebisu Garden Place in Tokyo, a popular tourist destination that consists of the Yebisu Brewery as well as fine dining and shopping options.

The investment consortium includes KKR and Asia-based investment firm PAG, with NHK reporting that the PE buyout fund plans to grow property profits by attracting new tenants to Yebisu Garden Place.

Redevelopment of the venue is also expected to be considered in the future.

Sapporo, meanwhile, plans to use the funds generated from the sale to invest in its beer business and other areas, to boost its core corporate value.

Sapporo, whose shares gained 2.86% following the announcement, and KKR did not immediately respond to CNBC's request for comments.

Stock Chart IconStock chart icon

This is not Sapporo's first attempt to offload its real estate business to the consortium. Back in October, Nikkei reported that the company had granted preferential negotiating rights to KKR and PAG, only to end exclusive talks the next month.

The report said the two sides were unable to agree on the sale price of the real estate business, as the properties in the portfolio "required significant and costly repairs due to aging facilities and the necessary implementation of safety measures."

At that time, Sapporo had opened the sale to other buyers and was reportedly approaching a consortium made up of private equity funds Lone Star Funds and real estate fund manager Kenedix.

Read the full NHK story here.

NEW YORK, Dec. 23, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of persons who invested in securities of SLM Corporation a/k/a Sallie Mae (NASDAQ: SLM) between July 25, 2025 and August 14, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 17, 2026.

SO WHAT: If you purchased SLM securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the SLM class action, go to https://rosenlegal.com/submit-form/?case_id=49601 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 17, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) SLM was experiencing a significant increase in early stage delinquencies; (2) accordingly, defendants overstated the effectiveness of SLM’s loss mitigation and/or loan modification programs, as well as the overall stability of SLM’s private education loan (“PEL”) delinquency rates; and (3) as a result, defendants’ public statements made a materially false and misleading impression regarding SLM’s business, operations, and prospects at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the SLM class action, go to https://rosenlegal.com/submit-form/?case_id=49601 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

The CNN Money Fear and Greed index showed further improvement in the overall market sentiment, while the index remained in the “Greed” zone on Tuesday.

U.S. stocks settled higher on Tuesday, with the S&P 500 settling at a record level during the session amid a surge in artificial intelligence names.

The New York Stock Exchange will close at 1 p.m. ET on Wednesday and will be closed on Thursday for Christmas Day.

Gross domestic product expanded at a 4.3% annualized pace in the third quarter, beating estimates near 3.3% and marking the fastest growth rate in two years.

That strength prompted traders to scale back expectations for near-term Federal Reserve easing. Markets now price roughly a 15% probability of a 25-basis-point cut in late January, down from 20% a day earlier. Expectations have narrowed to two cuts in 2026, with June and September seen as the most likely windows.

On the other economic data front, U.S. industrial production increased 0.1% per month across October and November. U.S. durable goods orders declined by 2.2% month-over-month to $307.4 billion in October, compared to a revised 0.7% growth from September, versus market estimates of a 1.5% decline.

Novo Nordisk A/S (NYSE:NVO) shares jumped more than 7% on Tuesday following FDA approval of its Wegovy pill.

Most sectors on the S&P 500 closed on a positive note, with communication services, information technology and energy stocks recording the biggest gains on Tuesday. However, consumer staples and health care stocks bucked the overall market trend, closing the session lower.

The Dow Jones closed higher by around 80 points to 48,442.41 on Tuesday. The S&P 500 rose 0.46% to 6,909.79, while the Nasdaq Composite jumped 0.57% to 23,561.84 during Tuesday's session.

What Is CNN Business Fear & Greed Index?At a current reading of 59.2, the index remained in the “Greed” zone on Tuesday, versus a prior reading of 57.3.

The Fear & Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.

Read Next:

Jim Cramer Is Bullish On This Tech Stock: ‘Continue To Own It’
Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Faraday Future and RAK Digital Assets Oasis (also known as RAK Innovation City) have entered into a strategic non-binding MOU to collaborate across three key areas: AI, Web3 and embodied intelligence.The two parties intend to explore the joint establishment of research and innovation centers to build a forward-looking, demonstrative industrial ecosystem.FF delivered the FX Super One to RAK Innovation City, the second FX Super One delivery in the UAE. The first FX Super One user in the UAE is global football legend Andrés Iniesta.FF has completed the delivery and transaction process for the Company’s next FF 91 2.0 Futurist Alliance vehicle with Hebron Sher, Co-Founder & CEO of ZEVO, with an upcoming delivery ceremony in January 2026. RAS AL KHAIMAH, United Arab Emirates and LOS ANGELES, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or the “Company”), a California-based global shared intelligent electric mobility ecosystem company, today announced that Faraday Future Middle East FZ-LLC has signed a memorandum of understanding (MOU) with RAK Digital Assets Oasis (also known as RAK Innovation City). Under the MOU, the two parties intend to cooperate across three major areas of exploration: artificial intelligence (AI), Web3 and the digital economy, and embodied intelligence.

Senior executives and distinguished guests attended the signing ceremony, including Paul Dawalibi, CEO of RAK Innovation City, Tin Mok, Head of FF Middle East, and Morris Gao, Head of User Ecosystem and Government Affairs at FF Middle East. Following the signing, FF also held a co-creation delivery ceremony, delivering the FX Super One to RAK Innovation City. This marks FF’s second delivery in the UAE. The Company has outlined its roadmap for its 2026 sales and deliveries in the UAE market and has iplans to initiate Phase II expansion of its Ras Al Khaimah regional factory and operations center to further enhance localized production capacity and support growing user demand and future FX Super One deliveries.

Under the strategic cooperation MOU, FF and Innovation City intend to explore the joint establishment research and innovation centers. By integrating respective technological capabilities, industrial resources, and ecosystem advantages, the two parties could carry out research, testing, and real-world application of technologies including AI, embodied intelligence, and Web3 in the UAE. Together, they aim to build a future-oriented industrial ecosystem and support Innovation City in becoming a forward-looking benchmark for next-generation urban and industrial development.

Paul Dawalibi, CEO of Ras Al Khaimah Innovation City, commented, “We are very pleased to establish a strategic relationship with FF. FF is not only one of Innovation City’s most important innovation partners, but also a long-term strategic partner aligned with our future-oriented vision. We look forward to working closely with FF to drive deep innovation across AI, embodied intelligence, and Web3, and we congratulate FX Super One on achieving success in the UAE MPV market as we jointly open a new milestone with Innovation City.”

Tin Mok, Head of FF UAE, stated, “RAK Innovation City is the world’s first future-focused urban development platform, strategically centered on cutting-edge technologies. By integrating government, enterprises, capital, and innovation resources, it has created a highly synergistic ecosystem combining technology, capital, talent, and policy. FF is delighted to enter into this strategic MOU with Innovation City. With its strong support, open collaboration, and business-friendly environment, we are highly confident that FF can leverage its extensive experience and technological capabilities in AI, Web3, and embodied intelligence to empower Innovation City for mutual success — writing a new chapter and creating new milestones together.”

FF currently operates a regional factory and operations center in Ras Al Khaimah, covering approximately 108,000 square feet, including office space, production workshops, and an operational hub. The facility is designed to support the production of both FF and FX vehicles. Through a combination of technology enablement and localized manufacturing, FF continues to promote the development of a new energy vehicle ecosystem across the Middle East.

ABOUT FARADAY FUTURE

Faraday Future is a California-based global shared intelligent electric mobility ecosystem company. Founded in 2014, the Company’s mission is to disrupt the automotive industry by creating a user-centric, technology-first, and smart driving experience. Faraday Future’s flagship model, the FF91, exemplifies its vision for luxury, innovation, and performance. The FX strategy aims to introduce mass production models equipped with state-of-the-art luxury technology similar to the FF 91, targeting a broader market with middle-to-low price range offerings. For more information, please visit https://www.ff.com/us/.

FORWARD LOOKING STATEMENTS    

This press release includes “forward looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements, which include statements regarding its plans with RAK Digital Assets Oasis, the Company’s plans to advance expansion of its operations facility in Ras Al Khaimah, are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements.

Important factors, among others, that may affect actual results or outcomes include, among others: the ability of the Company to enter into a binding agreement with RAK Digital Assets Oasis; the availability of sufficient share capital to execute on its strategy, which the Company currently lacks; the agreement of stockholders to substantially increase the Company’s share capital, which could result in substantial additional dilution; the Board’s approval of various production and sales plans and proposals, which the Company may fail to obtain; the Company's ability to homologate FX vehicles for sale; the Company’s ability to secure the necessary funding to execute on the FX strategy, which will be substantial; the Company’s ability to secure the rights to sell the Super One with the current AIHER powertrain in the UAE or elsewhere; the Company’s ability to secure the necessary funding to execute on the FX strategy, which will be substantial; the Company’s ability to continue as a going concern and improve its liquidity and financial position; the Company’s ability to pay its outstanding obligations; the Company's ability to remediate its material weaknesses in internal control over financial reporting and the risks related to the restatement of previously issued consolidated financial statements; the Company’s limited operating history and the significant barriers to growth it faces; the Company’s history of losses and expectation of continued losses; the success of the Company’s payroll expense reduction plan; the Company’s ability to execute on its plans to develop and market its vehicles and the timing of these development programs; the Company’s estimates of the size of the markets for its vehicles and cost to bring those vehicles to market; the rate and degree of market acceptance of the Company’s vehicles; the Company’s ability to cover future warranty claims; the success of other competing manufacturers; the performance and security of the Company’s vehicles; current and potential litigation involving the Company; the Company’s ability to receive funds from, satisfy the conditions precedent of and close on the various financings described elsewhere by the Company; the result of future financing efforts, the failure of any of which could result in the Company seeking protection under the Bankruptcy Code; the Company’s indebtedness; the Company’s ability to cover future warranty claims; the Company’s ability to use its “at-the-market” program; insurance coverage; general economic and market conditions impacting demand for the Company’s products; potential negative impacts of a reverse stock split; potential cost, headcount and salary reduction actions may not be sufficient or may not achieve their expected results; circumstances outside of the Company's control, such as natural disasters, climate change, health epidemics and pandemics, terrorist attacks, and civil unrest; risks related to the Company's operations in China; the success of the Company's remedial measures taken in response to the Special Committee findings; the Company’s dependence on its suppliers and contract manufacturer; the Company's ability to develop and protect its technologies; the Company's ability to protect against cybersecurity risks; and the ability of the Company to attract and retain employees, any adverse developments in existing legal proceedings or the initiation of new legal proceedings, and volatility of the Company’s stock price. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of the Company’s Form 10-K filed with the SEC on March 31, 2025, Form 10-Q filed on August 19, 2025, and other documents filed by the Company from time to time with the SEC.

CONTACTS:

Investors Relations (English): [email protected]   

Investors (Chinese): [email protected]   

Media: [email protected]   

Photos accompanying this announcement are available at https://www.globenewswire.com/NewsRoom/AttachmentNg/bac8df5a-27da-47aa-b8f1-87e68a33aafb

https://www.globenewswire.com/NewsRoom/AttachmentNg/3c037866-a54e-41d5-8ec5-6165f92877f3

https://www.globenewswire.com/NewsRoom/AttachmentNg/64b2bfba-5e11-4b55-b789-d2dcff877f56

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

NEW YORK and NEW ORLEANS, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until January 2, 2026 to file lead plaintiff applications in a securities class action lawsuit against CarMax, Inc. (NYSE: KMX), if they purchased or otherwise acquired the Company’s securities between June 20, 2025 and November 5, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Maryland.

What You May Do

If you purchased securities of CarMax and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-kmx/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by January 2, 2026.

About the Lawsuit

CarMax and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

On September 25, 2025, the Company announced its Second Quarter Fiscal Year 2026 financial results, disclosing among other things, that retail unit sales had decreased 5.4%, comparable store unit sales had decreased 6.3%, wholesale units had decreased 2.2%, and that net earnings per diluted share of $0.64 compared to $0.85 a year ago.

On this news, the price of CarMax’s shares fell $11.5 per share, or 20.07%, to close at $45.60 per share on September 25, 2025.

The case is Cap v. CarMax, Inc., No. 25-cv-03602.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:

Kahn Swick & Foti, LLC

Lewis Kahn, Managing Partner
[email protected] 
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

NEW YORK and NEW ORLEANS, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until January 26, 2026 to file lead plaintiff applications in a securities class action lawsuit against Sprouts Farmers Market, Inc. (“Sprouts” or the “Company”) (NasdaqGS: SFM), if they purchased or otherwise acquired the Company’s securities between June 4, 2025 and October 29, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Arizona.

What You May Do

If you purchased securities of Sprouts and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-sfm/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by January 26, 2026.

About the Lawsuit

Sprouts and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

On October 29, 2025, the Company announced its third quarter fiscal 2025 results, disclosing comparable stores sales growth below expectations as well as disappointing fourth quarter guidance and cuts to its full year estimates, despite raising them only one quarter prior, due to “challenging year-on-year comparisons as well as signs of a softening consumer.”

On this news, the price of Sprouts’ shares fell from a closing market price of $104.55 per share on October 29, 2025 to $77.25 per share on October 30, 2025, a decline of about 26.11% in the span of just a single day.

The case is Singh Family Revocable Trust u/a dtd 02/18/2019 v. Sprouts Farmers Market, Inc., et al., No. 25-cv-04416.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:

Kahn Swick & Foti, LLC

Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn